Effects of sea buckthorn oil intake on vaginal atrophy in postmenopausal women: A randomized,double-blind,placebo-controlled study |
| |
Authors: | Petra S. Larmo,Baoru Yang,Juha Hyssä lä ,Heikki P. Kallio,Risto Erkkola |
| |
Affiliation: | 1. Aromtech Ltd, Tornio, Finland;2. Food Chemistry and Food Development, Department of Biochemistry, University of Turku, Finland;3. Statfinn Ltd, Turku, Finland;4. Department of Obstetrics and Gynecology, University Central Hospital of Turku, Finland |
| |
Abstract: | BackgroundVaginal atrophy, the thinning and drying of vaginal mucosa, is associated with menopause. The standard estrogen treatment is not suitable for all women.ObjectiveTo investigate the effects of oral sea buckthorn (SB) oil supplementation on vaginal atrophy.MethodA total of 116 postmenopausal women experiencing symptoms of vaginal dryness, itching or burning were randomized to this placebo-controlled, double-blind study. Ninety-eight participants completed the intervention of three months, during which they consumed 3 g of SB or placebo oil daily. At the beginning and end, factors of vaginal health were scored by a gynecologist, vaginal pH and moisture were measured and vaginal health index was calculated. Symptoms of atrophy and menopause were evaluated at study visits and by daily logbooks. Serum samples were collected for the analysis of circulating lipids, liver enzymes and C-reactive protein.ResultsCompared to placebo, there was a significantly better rate of improvement in the integrity of vaginal epithelium in the SB group when both compliant and noncompliant participants were included (odds ratio (OR) = 3.1, 95% CI 1.11–8.95). A beneficial trend was observed when only the compliant participants were included (OR = 2.9; 95% CI 0.99–8.35). There was a tendency (P = 0.08) toward better improvement of vaginal health index from baseline to the end in the SB group [(0.8 (SD 2.8)] compared to placebo [−0.1 (SD 2.0)].ConclusionsSB oil showed beneficial effects on vaginal health, indicating it is a potential alternative for mucosal integrity for those women not able to use estrogen treatment for vaginal atrophy. |
| |
Keywords: | ALA, α-linolenic acid ALT, alanine aminotransferase AST, aspartate aminotransferase BL, baseline CI, confidence interval CRP, C-reactive protein EPA, eicosapentaenoic acid HDL, high density lipoprotein ITT, intention to treat LA, linoleic acid LDL, low density lipoprotein MI, maturation index OR, odds ratio PP, per protocol Q1, lower quartile Q3, upper quartile SD, standard deviation SB, sea buckthorn VagHI, vaginal health index |
本文献已被 ScienceDirect 等数据库收录! |
|